Europe: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
AI-assisted Neurosurgery: Balancing Innovation And Risk
The world's first live AI-assisted brain surgery marks a pivotal moment in healthcare innovation, demonstrating how artificial intelligence can augment clinical expertise during complex neurosurgical procedures. As this technology becomes more prevalent in NHS and private medical settings, what governance frameworks and risk management strategies must healthcare organizations implement to balance innovation with patient safety? This analysis explores the opportunities, challenges, and critical consideration
United Kingdom Healthcare
BJ
Browne Jacobson
Article
Could Aesthetic Devices Face Greater Regulation? What Providers Need To Know About The MHRA’s Latest Proposals
The UK government has proposed amendments to the Health Bill that could introduce an MHRA licensing regime for medical devices used in aesthetic treatments. While no new requirements are in effect yet, these enabling provisions signal a shift toward greater regulatory oversight of the devices and technologies increasingly used in non-surgical cosmetic procedures, prompting providers to review their equipment governance and compliance frameworks.
United Kingdom Healthcare
JS
JMW Solicitors LLP
See more

Food and Drugs Law

Article
Could Aesthetic Devices Face Greater Regulation? What Providers Need To Know About The MHRA’s Latest Proposals
The UK government has proposed amendments to the Health Bill that could introduce an MHRA licensing regime for medical devices used in aesthetic treatments. While no new requirements are in effect yet, these enabling provisions signal a shift toward greater regulatory oversight of the devices and technologies increasingly used in non-surgical cosmetic procedures, prompting providers to review their equipment governance and compliance frameworks.
United Kingdom Healthcare
JS
JMW Solicitors LLP
Article
EU Pharma Package: New Incentives For Innovation In Antibiotics
The EU Pharma Package introduces a novel approach to combat antimicrobial resistance through transferable exclusivity vouchers that reward innovation in priority antimicrobials while simultaneously implementing stricter antibiotic stewardship measures. This regulatory framework attempts to resolve the fundamental tension between incentivizing pharmaceutical companies to develop new antibiotics and ensuring these critical medicines are used prudently to prevent further resistance development.
European Union Healthcare
CMS Wistrand
See more

Healthcare

Article
AI-assisted Neurosurgery: Balancing Innovation And Risk
The world's first live AI-assisted brain surgery marks a pivotal moment in healthcare innovation, demonstrating how artificial intelligence can augment clinical expertise during complex neurosurgical procedures. As this technology becomes more prevalent in NHS and private medical settings, what governance frameworks and risk management strategies must healthcare organizations implement to balance innovation with patient safety? This analysis explores the opportunities, challenges, and critical consideration
United Kingdom Healthcare
BJ
Browne Jacobson
Article
Could Aesthetic Devices Face Greater Regulation? What Providers Need To Know About The MHRA’s Latest Proposals
The UK government has proposed amendments to the Health Bill that could introduce an MHRA licensing regime for medical devices used in aesthetic treatments. While no new requirements are in effect yet, these enabling provisions signal a shift toward greater regulatory oversight of the devices and technologies increasingly used in non-surgical cosmetic procedures, prompting providers to review their equipment governance and compliance frameworks.
United Kingdom Healthcare
JS
JMW Solicitors LLP
See more

Life Sciences, Biotechnology & Nanotechnology

Article
Miniaturisation And Patentability: Why Scaling Down A Product Is Not Enough To Qualify As A Patentable Invention
Modern engineering increasingly prioritizes making products smaller, lighter, and more portable, but does miniaturization alone constitute a patentable invention? Patent law requires more than impressive size reduction—it demands non-obvious technical solutions to specific problems created by scaling down, such as thermal management, signal integrity, or mechanical stress challenges.
France IP
HL
HGF Ltd
Article
Gene-edited "Sunshine" Tomato Receives First Marketing Approval In England
The UK has approved a marketing notice for the "Sunshine" tomato, a gene-edited variety engineered to contain elevated levels of provitamin D3. This milestone marks the first precision-bred tomato to receive approval under England's post-Brexit regulatory framework, bringing a new dietary source of vitamin D closer to commercialisation while demonstrating the practical implementation of the Genetic Technology (Precision Breeding) Act 2023.
United Kingdom Healthcare
MC
Marks & Clerk
Article
The EU Pharma Package: Upcoming Reform Of Regulatory Data Exclusivity And Market Protection For Approved Medicines For Human Use
The European Parliament and Council have agreed on the most significant reform of EU pharmaceutical legislation in two decades, fundamentally restructuring the regulatory data exclusivity and market protection framework for newly approved medicines. While the baseline eight-year data protection period remains unchanged, the market exclusivity system has been overhauled with a new modulated approach that reduces automatic protection and requires pharmaceutical companies to complete specific clinical studies
European Union Healthcare
PS
Penningtons Manches Cooper LLP
See more

Latest Videos

See more